Particle Therapy in Cancer Treatment: A Paradigm-Shifting Advancement in Radiotherapy

Abstract

Particle therapy constitutes a major advance in contemporary oncology by enabling highly precise radiation delivery using protons and carbon ions. Unlike conventional radiotherapy, its physical advantages particularly the Bragg peak alow maximal dose deposition within the tumor while significantly reducing exposure to surrounding healthy tissues. This improves local control and decreases acute and late toxicities, especialy in tumors near critical structures or with marked radio resistance. Clinical experience in specialized centers, such as MedAustron and CNAO, has shown favorable outcomes in pediatric and adult populations, including cases requiring re-irradiation. Emerging modalities such as helium ion therapy may offer intermediate radiobiological benefits, though further clinical validation is needed. Persistent cha lenges include limited availability worldwide and the need for stronger comparative evidence. Overal, particle therapy broadens therapeutic possibilities and strengthens the future of precision oncology.